Skip to main content
. 2015 Dec 9;7(3):3098–3110. doi: 10.18632/oncotarget.6521

Table 1. Univariate and multivariate Cox regression analysis for the association of ANXA1 staining with TTP.

Univariate Multivariate
n of patients HR 95% CI P HR 95% CI P
ANXA1
Negative 272 1.00 1.00
Positive 45 2.99 2.14 – 4.16 < 0.001 1.82 1.12 – 3.00 0.016
Age
≤ 55 years 125 1.00 1.00
> 55 years 192 0.59 0.47 – 0.75 < 0.001 0.56 0.42 – 0.75 < 0.001
Disease-free survival
≤ 12 months 67 1.00 1.00
> 12 months 250 0.69 0.52 – 0.91 0.008 0.72 0.51 – 1.01 0.057
Dominant site of relapse
Loco-regional 43 1.00
Bone 113 1.20 0.83 – 1.74 0.235
Visceral 74 1.27 0.85 – 1.89 0.238
Bone and other 87 1.25 0.85 – 1.84 0.258
PgR*
Negative 111 1.00 1.00
Positive 204 0.51 0.40 – 0.64 < 0.001 0.71 0.52 – 0.97 0.034
Her2 status*
Negative 201 1.00
Positive 114 1.18 0.93 – 1.50 0.170
Tumor differentiation*
Good 46 1.00 1.00
Moderate 150 1.45 1.01 – 2.06 0.042 1.15 0.79 – 1.67 0.456
Poor 118 1.95 1.35 – 2.82 < 0.001 1.24 0.82 – 1.89 0.311
*

Missing data not reported.

Tumor differentiation was assessed through Bloom-Richardson scoring system.

Acronym: PgR: progesterone receptor.